Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 2Pulmonary Disease, Chronic Obstructive 1Polycystic Ovary Syndrome 1Disease 1Diabetes Mellitus, Type 2 1

Interventions

Metformin 21Inositol 13Letrozole 9Exercise 5Surveys and Questionnaires 4Clomiphene 4Tablets 3Estradiol 3semaglutide 2maltodextrin 2drospirenone and ethinyl estradiol combination 2Spironolactone 2Progesterone 2Ethinyl Estradiol 2Diet Therapy 2Contraceptives, Oral, Combined 2Caloric Restriction 2Acupuncture Therapy 2salicylsalicylic acid 1mirabegron 1etonogestrel 1drospirenone 1dapagliflozin 1cetrorelix 1Walking 1Tirzepatide 1Thyroxine 1Thioctic Acid 1Tamoxifen 1Sodium-Glucose Transporter 2 Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Polycystic Ovary Syndrome × Sodium-Glucose Transporter 2 Inhibitors × 1 year × Clear all
NCT05966792 2026-04-13

SGLT2 Inhibitors in Treating Patients With PCOS

Shanghai 10th People's Hospital

Phase NA Completed
82 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡